Zyla offers next-generation Medical AI to treat diabetes and co-morbidities. Zyla has developed a deep learning-enabled “medical brain”, which analyzes millions of data points across the patient history in real-time to deliver the most personalized medical interventions. The chat-based product sees high engagement time of more than 7 mins per patient per day and strong clinical outcomes to the tune of 12.88% reduction in HbA1c levels.